overall survival

You have access
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen–Directed Radioligand Therapy
Philipp E. Hartrampf, Patrick W. Mihatsch, Anna Katharina Seitz, Lilja B. Solnes, Steven P. Rowe, Martin G. Pomper, Hubert Kübler, Thorsten A. Bley, Andreas K. Buck and Rudolf A. Werner

Journal of Nuclear Medicine June 8, 2023, jnumed.122.265379; DOI: https://doi.org/10.2967/jnumed.122.265379
You have access
Survival Outcomes in Metastatic Gastroenteropancreatic Neuroendocrine Tumor Patients Receiving Concomitant ²²⁵Ac-DOTATATE–Targeted α-Therapy and Capecitabine: A Real-World-Scenario Management-Based Long-Term Outcome Study
Sanjana Ballal, Madhav P. Yadav, Madhavi Tripathi, Ranjit Kumar Sahoo and Chandrasekhar Bal

Journal of Nuclear Medicine February 1, 2023, 64 (2) 211-218; DOI: https://doi.org/10.2967/jnumed.122.264043
You have access
¹⁸F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer
Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers and Joel Castelli

Journal of Nuclear Medicine September 1, 2022, 63 (9) 1378-1385; DOI: https://doi.org/10.2967/jnumed.121.262891
You have access
Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection
Jihye Kim, Ju Yeon Kim, Jeong-Hoon Lee, Dong Hyun Sinn, Moon Haeng Hur, Ji Hoon Hong, Min Kyung Park, Hee Jin Cho, Na Ryung Choi, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jin Chul Paeng, Hyo Cheol Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Dongho Hyun, Jong Man Kim and Jung-Hwan Yoon

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1215-1222; DOI: https://doi.org/10.2967/jnumed.121.263147
You have access
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with ¹⁸F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study
Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas

Journal of Nuclear Medicine August 1, 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602
You have access
⁶⁴Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Jann Mortensen, Peter Oturai, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge and Andreas Kjaer

Journal of Nuclear Medicine October 1, 2020, 61 (10) 1491-1497; DOI: https://doi.org/10.2967/jnumed.119.240143
You have access
First-Line Selective Internal Radiation Therapy in Patients with Uveal Melanoma Metastatic to the Liver
Alexandre Ponti, Alban Denys, Antonia Digklia, Niklaus Schaefer, Arnaud Hocquelet, Jean-François Knebel, Olivier Michielin, Clarisse Dromain and Rafael Duran

Journal of Nuclear Medicine March 1, 2020, 61 (3) 350-356; DOI: https://doi.org/10.2967/jnumed.119.230870
You have access
Metabolic Tumor Volume for Response Prediction in Advanced-Stage Hodgkin Lymphoma
Jasmin Mettler, Horst Müller, Conrad-Amadeus Voltin, Christian Baues, Bernd Klaeser, Alden Moccia, Peter Borchmann, Andreas Engert, Georg Kuhnert, Alexander Drzezga, Markus Dietlein and Carsten Kobe

Journal of Nuclear Medicine February 1, 2019, 60 (2) 207-211; DOI: https://doi.org/10.2967/jnumed.118.210047
You have access
Differentiated Thyroid Cancer Patients More Than 60 Years Old Paradoxically Show an Increased Life Expectancy
Tobias Markus Maier, Otmar Schober, Joachim Gerß, Dennis Görlich, Christian Wenning, Michael Schaefers, Burkhard Riemann and Alexis Vrachimis

Journal of Nuclear Medicine February 1, 2015, 56 (2) 190-195; DOI: https://doi.org/10.2967/jnumed.114.150284
You have access
3′-Deoxy-3′-¹⁸F-Fluorothymidine PET–Derived Proliferative Volume Predicts Overall Survival in High-Grade Glioma Patients
Albert J.S. Idema, Aswin L. Hoffmann, Hieronymus D. Boogaarts, Esther G.C. Troost, Pieter Wesseling, Arend Heerschap, Winette T.A. van der Graaf, J. Andre Grotenhuis and Wim J.G. Oyen

Journal of Nuclear Medicine December 1, 2012, 53 (12) 1904-1910; DOI: https://doi.org/10.2967/jnumed.112.105544

Main menu

User menu

Search

overall survival